2 months ago
SABS
AnalystsKeay NakaeKeay Nakae's Stock Forecasts
AnalystsKeay Nakae
Analyst Ranking
Top 5%
#245 out of 5266 analysts
Average Return
+15.53%
Win Rate
38%110 out of 293
Risk vs Reward
Poor
Good
Keay Nakae's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ocugen IncOCGN | +5,554.71% | $0.22 | $12.61 | 2020-06-03 - 2021-02-09 | Strong Buy |
Arrowhead Pharmaceuticals IncARWR | +389.59% | $15.28 | $74.81 | 2025-05-13 - 2026-05-01 | Strong Buy |
Avidity Biosciences IncRNAM | +347.81% | $9.35 | $41.87 | 2023-08-09 - 2024-08-08 | Strong Buy |
Arrowhead Pharmaceuticals IncARWR | +334.69% | $17.21 | $74.81 | 2025-08-11 - 2026-05-01 | Strong Buy |
Dyne Therapeutics IncDYN | +253.51% | $11.55 | $40.83 | 2023-08-04 - 2024-08-02 | Strong Buy |
Keay Nakae Analyst Color
Get additional color on Keay Nakae's coverage of popular stocks
2 months ago
ALUR
3 months ago
KRRO
7 months ago
MNPR
a year ago
RNAM
a year ago
ABUS
a year ago
ABUS
2 years ago
RNAM
2 years ago
RNAM
2 years ago
SLN
2 years ago
RNAM
2 years ago
DYN
2 years ago
COYA
2 years ago
SLN
2 years ago
PRQR
2 years ago
DYN
2 years ago
RNAM
3 years ago
COYA
3 years ago
SYBX
3 years ago
GANX
3 years ago
DYN
4 years ago
ALNY
4 years ago
BTTX
4 years ago
BTTX
4 years ago
ABUS
Keay Nakae's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alto Neuroscience IncANRO | 4 | Strong Buy | $30.00 | +20.29% | Maintains | 11 days ago |
Proqr Therapeutics NvPRQR | 14 | Strong Buy | $4.00 | +158.06% | Maintains | 24 days ago |
Ibio IncIBIO | 8 | Strong Buy | $5.00 | +214.47% | Maintains | 24 days ago |
Monopar TherapeuticsMNPR | 8 | Strong Buy | $100.00 | +87.79% | Maintains | a month ago |
Alnylam Pharmaceuticals IncALNY | 14 | Strong Buy | $425.00 | +43.53% | Maintains | a month ago |
Stoke Therapeutics IncSTOK | 2 | Strong Buy | $35.00 | +5.80% | Maintains | 2 months ago |
Coya Therapeutics IncCOYA | 24 | Strong Buy | $14.00 | +235.73% | Maintains | 2 months ago |
Orchestra Biomed Holdings IncOBIO | 14 | Strong Buy | $20.00 | +403.78% | Maintains | 2 months ago |
Sab Biotherapeutics IncSABS | 19 | Strong Buy | $14.00 | +303.46% | Maintains | 2 months ago |
Dyne Therapeutics IncDYN | 16 | Strong Buy | $38.00 | +118.52% | Maintains | 2 months ago |
Allurion Technologies IncALUR | 7 | Strong Buy | $3.00 | +679.22% | Upgrades | 2 months ago |
Korro Bio IncKRRO | 5 | Strong Buy | $15.00 | +10.54% | Upgrades | 3 months ago |
Arrowhead Pharmaceuticals IncARWR | 19 | Strong Buy | $80.00 | +6.94% | Maintains | 4 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 1 | Strong Buy | $40.00 | +4,445.45% | Maintains | 4 months ago |
Arbutus Biopharma CorpABUS | 13 | Strong Buy | $5.00 | +15.74% | Maintains | 6 months ago |
Avidity Biosciences IncRNAM | 21 | Hold | $72.00 | +388.14% | Maintains | 6 months ago |
Silence Therapeutics PLCSLN | 13 | Strong Buy | $35.00 | +390.88% | Maintains | 9 months ago |
Seres Therapeutics IncMCRB | 10 | Hold | $6.00 | -21.16% | Downgrades | a year ago |
Sonnet Biotherapeutics Holdings IncSONN | 13 | Strong Buy | $20.00 | N/A | Maintains | a year ago |
Gain Therapeutics IncGANX | 6 | Strong Buy | $6.00 | N/A | Maintains | a year ago |
Femasys IncFEMY | 10 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Omega Therapeutics IncOMGAQ | 6 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Notable Labs LtdNTBLQ | 2 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Synlogic IncSYBX | 4 | Strong Buy | $90.00 | N/A | Reiterates | 3 years ago |
Better Therapeutics IncBTTX | 6 | Strong Buy | $9.00 | N/A | Reiterates | 3 years ago |
Mesoblast LtdMESO | 7 | Strong Sell | $6.00 | N/A | Maintains | 3 years ago |
Pear Therapeutics IncPEARQ | 5 | Hold | $8.00 | N/A | Downgrades | 3 years ago |
Evelo Biosciences IncEVLO | 4 | Hold | $50.00 | N/A | Downgrades | 3 years ago |
Biomx IncPHGE | 4 | Strong Buy | $380.00 | N/A | Maintains | 3 years ago |
Emergent Biosolutions IncEBS | 8 | Strong Buy | $55.00 | N/A | Maintains | 3 years ago |
Axcella Health IncAXLA | 4 | Strong Buy | $125.00 | N/A | Maintains | 4 years ago |
Neubase Therapeutics IncNBSE | 5 | Hold | N/A | N/A | Downgrades | 4 years ago |
Exicure IncXCUR | 5 | Hold | $10.00 | N/A | Maintains | 4 years ago |
4d Pharma PLCLBPS | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Kaleido Biosciences IncKLDO | 3 | Hold | $1.70 | N/A | Downgrades | 4 years ago |
Dicerna Pharmaceuticals IncDRNA | 3 | Hold | $38.25 | N/A | Downgrades | 4 years ago |
Forte Biosciences IncFBRX | 2 | Hold | $87.50 | N/A | Upgrades | 5 years ago |
Ocugen IncOCGN | 2 | Hold | $13.00 | N/A | Downgrades | 5 years ago |
Insight Molecular Diagnostics IncIMDX | 2 | Hold | $40.00 | N/A | Downgrades | 6 years ago |
Lisata Therapeutics IncLSTA | 1 | Strong Buy | $7.00 | N/A | Maintains | 8 years ago |
Carecloud IncCCLD | 1 | Strong Buy | $2.75 | N/A | Maintains | 8 years ago |
Biocept IncBIOCQ | 1 | Strong Buy | $22,500.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.